From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata

    November 2015 in “ ˜The œjournal of investigative dermatology. Symposium proceedings/˜The œJournal of investigative dermatology symposium proceedings ”
    Dory Kranz, Abby Ellison, Jeffrey A. Frelinger, Julian Mackay‐Wiggan, David A. Norris
    TLDR Alopecia areata is now understood to be driven by genetic and immune factors.
    Alopecia areata, affecting over 146 million people globally, is an autoimmune disease causing hair loss. The National Alopecia Areata Foundation (NAAF), established in 1981, supports research, patient support, and public education. NAAF's biennial research summits, part of the Alopecia Areata Treatment Development Program, have significantly shifted the understanding of the disease from inflammatory and dermatological views to recognizing genetic and immunological factors as key drivers.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Pattern hair loss could be due to gut bacteria

       48 upvotes 4 years ago
      Feeding bacteria-free mice with Lactobacillus murinus worsened hair loss, but a regular diet with biotin stopped it. The conversation suggests gut bacteria and diet may influence hair loss, with some skepticism and discussion about other factors like DHT and genetics.

      community 1ish year on fin and no improvement

      in Is this regrowth?  86 upvotes 2 months ago
      The user has been using finasteride for over a year without improvement and recently started oral minoxidil. Suggestions include trying dutasteride and continuing minoxidil for potential regrowth.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Related Research

    3 / 3 results